Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYTEL: TBEV Vaccination in CMV+ vs CMV- Elderly
NCT00461695Phase 4Completed
- Sponsor
- University of Zurich
- Start
- May 2007
- Primary completion
- Aug 2008
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by University of Zurich. Started May 2007; status: completed.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on NCT00461695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00461695.